Pharma Generics
Overview
United States
Other Regulated Markets
Branded Generics
Overview
Africa
Institutional Business
Overview
Business Segments
About Strides
Who We Are
Vision & Mission
Board of Directors
Leadership Team
R&D
Environmental Health & Safety
synergICE
Investors - Disclosures under Regulation 46 of SEBI LODR’
Advertisements
Board of Directors
Board Committees
Corporate Governance
Annual Return
Corporate Policies
Secretarial Compliance Report
Corporate Social Responsibilty
Financials
IEPF
Key Managerial Personnel
Investors Presentation
Shareholders’ Service Request
Shareholder Information
Shareholding Pattern Report
Subsidiary Financials
Tax on Final Dividend 2020-21
Media
Press Releases / Stock Exchange Intimation
Strides in the News
Careers
Our Culture
Working at Strides
Leadership Training and Development
Opportunities at Strides
Search for Jobs Now
International Headquarters - Singapore
Contact Us
General
Pharma
Branded Generics
Investor query
Investor Contacts
Media
Careers
Adverse Event / Product Complaint
Archival
L-gest
L-Gest Tablet
Composition:
Each uncoated tablet contains Levonorgestrel BP 1.5 mg.
Prescribing Information
Therapeutic Category
Antianemic
Vitafer
Antidiabetic
Adride
Glim Forte
Anti-infective
Azithrin
Betazidim
Celltriaxon
Claritron
Clavicin
KNZ
Anti-malarial
Combiart
Duotab
Cardiovascular
Amlostar
Fliptor
Lipovas
Teltartan
Dermatological
Nofong
Gastrointestinal
Laxmag
Setronax
Solcer
Management of Neuropathy
PregaNerve
Renerve
Management of Pain
Melonax
Strimol Extra
Others
Camvit Plus
Dubix
Erekta
L-gest
Lorhist
Prescribing Information